93/12
Pill imprint 93/12 has been identified as Pantoprazole sodium delayed-release 40 mg.
Pantoprazole is used in the treatment of stomach ulcer; gerd; peptic ulcer; erosive esophagitis; barrett's esophagus (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy.
Pantoprazole 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Pantoprazole sodium delayed-release Images
- Imprint:
-
93/12
- Strength:
- 40 mg
- Color:
- Yellow
- Size:
- 10.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium carbonate
calcium stearate
D&C Yellow No. 10
aluminum oxide
FD&C Yellow No. 6
hypromelloses
ferrosoferric oxide
ferric oxide yellow
lactose monohydrate
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polyethylene glycol
shellac
sodium carbonate
stearic acid
magnesium silicate
titanium dioxide
triethyl citrate
propylene glycol
soya lecithin
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-0012
| NDC Code | Manufacturer / Repackager |
|---|---|
| 18837-0296 | Innoviant Pharmacy Inc (repackager) |
| 54868-5846 | Physicians Total Care Inc (repackager) |
| 68071-0782 | Nucare Pharmaceuticals Inc (repackager) |
| 66336-0405 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More Pantoprazole Sodium Delayed-Release resources
- Pantoprazole (Wolters Kluwer)
- Pantoprazole Delayed-Release Tablets (Wolters Kluwer)
- Pantoprazole Suspension (Wolters Kluwer)
- pantoprazole (Cerner Multum)
- pantoprazole (Micromedex) - Includes Dosage Information
- pantoprazole Intravenous (Micromedex) - Includes Dosage Information
- Pantoprazole Sodium (AHFS DI)
- Pantoprazole (FDA)
- Protonix Tablets (FDA)
- Pantoprazole Sodium (Wolters Kluwer)


